Neolife SA (ALNLF.PA)

EUR 0.06

(0.98%)

EBITDA Summary of Neolife SA

  • Neolife SA's latest annual EBITDA in 2023 was 133.43 Thousand EUR , up 139.79% from previous year.
  • Neolife SA's latest quarterly EBITDA in 2024 Q2 was 295 Thousand EUR , down 0.0% from previous quarter.
  • Neolife SA reported an annual EBITDA of -3.04 Million EUR in 2022, down -239.94% from previous year.
  • Neolife SA reported an annual EBITDA of 367.71 Thousand EUR in 2021, up 64.58% from previous year.
  • Neolife SA reported a quarterly EBITDA of N/A for 2023 FY, up 139.79% from previous quarter.
  • Neolife SA reported a quarterly EBITDA of 5.3 Million EUR for 2023 Q4, down 0.0% from previous quarter.

Annual EBITDA Chart of Neolife SA (2023 - 2015)

Historical Annual EBITDA of Neolife SA (2023 - 2015)

Year EBITDA EBITDA Growth
2023 133.43 Thousand EUR 139.79%
2022 -3.04 Million EUR -239.94%
2021 367.71 Thousand EUR 64.58%
2020 338.88 Thousand EUR 274.23%
2019 -81.99 Thousand EUR -15639.21%
2018 -939.44 Thousand EUR 51.41%
2017 -1.21 Million EUR -6.11%
2016 -1.29 Million EUR 99.93%
2015 -2.19 Million EUR 0.0%

Peer EBITDA Comparison of Neolife SA

Name EBITDA EBITDA Difference
Miliboo Société anonyme 3.13 Million EUR 95.741%
U10 Corp 2.91 Million EUR 95.424%
Belysse Group NV 31.08 Million EUR 99.571%
Roche Bobois S.A. 92.84 Million EUR 99.856%
SEB SA 913.6 Million EUR 99.985%
Vista Alegre Atlantis, SGPS, S.A. 29.17 Million EUR 99.543%